News | November 01, 2024
Supriya Lifescience reports 19% revenue increase in Q2 FY25
The company reported a net profit of Rs 46.15 crore in Q2 FY25 as compared to Rs 23.88 crore in Q2 FY24
The company reported a net profit of Rs 46.15 crore in Q2 FY25 as compared to Rs 23.88 crore in Q2 FY24
Product basket comprises 2,047 medicines and 300 surgical devices covering all major therapeutic groups
Infant Mortality Rate in Bihar came down from 42 to 27 in 2020, and in Jharkhand, from 34 to 25 in 2020
Spread over 1.26 lakh sq ft building, the super-specialty eye hospital will perform 30,000 free eye surgeries annually for economically weaker sections
The first phase of the Aptivate Achi Bhookh Fest reached over 8,200 households
India has been declared ‘functional’ against all the core regulatory functions of the WHO Global Benchmarking Tool Version VI
Aims to achieve CDMO sales of US$ 400 million by 2028
Mylan and Novo Nordisk reach settlement of US patent litigation related to Ozempic
DKSH has entered into an exclusive partnership with R-Biomeds to bring the necessary medication to patients in Cambodia
Strategic focus on COCO-model with a nationwide reach of 501 stores
Subscribe To Our Newsletter & Stay Updated
